Sunwin Stevia International Facility Now Capable of Commercial Production of A3-99 Stevia Products
Sunwin Stevia has completed testing for this production process making it one of a select few producers of A3-99 in China. Management expects to begin delivering shipments of the A3-99 to Zhejiang Huisong Pharmaceuticals, a pharmaceutical customer in China, in the fourth quarter of fiscal 2013 which begins in February 2013.
08 Jan 2013 --- Sunwin Stevia International, Inc. "Sunwin Stevia" one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced that its facilities are now capable of producing A3-99 stevia products. The addition of A3-99 to its commercial production capabilities is part of its previously announced stevioside expansion project.
A3-99 extracts are among the highest quality stevioside extracts produced in the world and are used in the pharmaceutical and food and beverage industries. Sunwin Stevia has completed testing for this production process making it one of a select few producers of A3-99 in China. Management expects to begin delivering shipments of the A3-99 to Zhejiang Huisong Pharmaceuticals, a pharmaceutical customer in China, in the fourth quarter of fiscal 2013 which begins in February 2013. Sunwin also intends to seek patents in China for its A3-99 production methodology.
"We are excited to add A3-99 to our commercial product offerings making Sunwin Stevia one of a select few suppliers capable of producing this extract on a large scale. Our recent facility upgrade has substantially increased our overall capabilities and we anticipate further additions to our production capabilities as we continue testing and trial production runs," commented Dongdong Lin , CEO of Sunwin Stevia. "We believe our technology is state of the art and we intend to seek a patent for our methodologies. We look forward to actively marketing our A3-99 stevia in China and eventually in the international markets in the coming quarters."
